Washington D.C. Medical Cannabis Sales Reach $47 Million in 2026 as Patient Count Reaches 123,826
- Washington D.C.’s medical cannabis sales stayed above $10 million in May 2026, totaling $10,021,299, slightly down from April’s record $10.4 million but showing an 11.6% increase from May 2025.
- Dispensaries dominated the market with $6.7 million in May sales, while cultivation centers and manufacturers saw decreases compared to April; total sales for the first five months of 2026 reached $47 million.
- The patient base grew significantly in May, with 123,826 registered patients and 42,153 unique dispensary patients; sales to D.C. residents rose to $4.16 million, and non-resident temporary patients and reciprocity patients also contributed notable sales.
- Flower was the top-selling product category at $3.37 million in May, followed by vape cartridges, infused edibles, and pre-rolls; enforcement included one violation, 13 inspections, and the closure of three unlicensed facilities, adding to 111 closures district-wide.
Washington D.C.’s medical cannabis market remained above $10 million in May after setting a record of $10.4 million in April, according to the newest report from the Alcoholic Beverage and Cannabis Administration.
The district reported $10,021,299 in total medical cannabis sales for May, down from April’s record $10,404,293 but still well above the $9,300,768 sold in March. The May total also marks an 11.6% increase from the $8,982,688 reported in May 2025.
Through the first five months of 2026, D.C.’s medical cannabis program has generated $47 million in sales. That includes $8.7 million in January, $8.5 million in February, $9.3 million in March, $10.4 million in April and $10 million in May.
Dispensaries continued to make up the largest share of the market, bringing in $6,710,655 in May sales, up from $6,519,001 in April and $6,255,850 in March. Cultivation centers reported $727,036 in sales, down from $822,068 the previous month, while manufacturers brought in $2,583,608, also down from April’s $3,063,224.
The district’s patient base continued to grow. Total registered D.C. resident patients reached 123,826 in May, up from 116,647 in April and 109,686 in March. The number of unique patients served by a registered dispensary increased to 42,153, compared to 39,627 in April. The number of retailers dipped from 69 to 68.
For D.C. residents specifically, total sales reached $4,164,888 in May, up from $4,006,464 in April. Unique resident patients increased to 25,477, while total unique sales rose to 70,935. In-store sales accounted for most resident activity, with $3,904,538 in sales, while delivery sales totaled $260,350.
Non-D.C. resident self-certified temporary patients continued to represent a large portion of the market. Sales in that category reached $2,097,638 in May, up slightly from $2,079,231 in April. The number of registered temporary patients for the month grew to 13,398, while 14,329 unique temporary patients made purchases.
Reciprocity patients accounted for $448,129 in May sales, up from $433,306 the month before. The number of unique reciprocity patients who made purchases increased from 1,944 to 2,349.
Among retailer sales by product type, flower remained the top category, with $3,365,547 in May sales from 776 pounds sold. Vape cartridges followed at $1,216,765, while infused edibles reached $841,749. Raw pre-rolls also continued to climb, increasing to $808,931 after reaching $705,643 in April and $636,519 in March.
The May report also shows one violation observed, 13 scheduled inspections and three unlicensed facilities closed. ABCA reported 1,420 pounds of cannabis waste destroyed during the month.
The unlicensed businesses closed in May were Green Cloud at 6124 Georgia NE, Miami Breeze at 3630 Georgia Ave NW and Green Magic at 3013 Georgia Ave NW. The report lists 111 unlicensed facilities closed across the district to date, with Ward 1 accounting for the most at 36.